BiomX : CONSOLIDATED FINANCIAL STATEMENTS DECEMBER 31, 2022 CONTENTS - Form 8-K -December 07, 2023 at 04:14 pm EST

CONSOLIDATED FINANCIAL STATEMENTS
DECEMBER 31, 2022


CONTENTS








Page




...

Related Keywords

Delaware ,United States ,Connecticut ,Ness Ziona ,Hamerkaz ,Israel ,Credit On ,Devon ,United Kingdom ,Japan ,American ,America ,State Of Israel ,Israeli ,Kesselman ,Stock Exchange ,Boehringer Ingelheim International Gmb ,Biomx Inc ,Securities Exchange ,Company Common Stock ,Company Ability To ,Pricewaterhousecoopers International ,Cystic Fibrosis Foundation Cf ,World Health Organization On ,Maruho Co ,Company Primary Sclerosing Cholangitis ,Israel Innovation Authority ,Rondinx Ltd ,Company Phase ,Company On ,Exchange Commission On ,Leumi Bank Israel ,Keio University ,Exchange Commission ,United Kingdom Financial Conduct Authority ,Aviv Stock Exchange ,Public Accounting Firm ,Public Company Accounting Oversight Board United States ,Hercules Capital Inc ,Company Board Of Directors The ,Company Or Biom ,Cf Foundation ,Yeda Research ,Biomx Ltd ,Most Of The Company ,Development Company Limited Yeda ,Massachusetts Institute Of Technology ,Consolidated Financial ,Independent Registered Public Accounting ,Public Company Accounting Oversight Board ,Public Accountants ,Pricewaterhousecoopers International Limited ,Common Stock ,Open Market Sales Agreement ,Securities Purchase Agreement ,Stock Purchase Agreement ,Biomx Israel ,Tel Aviv Stock ,Tel Aviv Stock Exchange ,World Health Organization ,Value Measurements ,Cystic Fibrosis Foundation ,Severance Compensation Act ,Israeli Severance Compensation Act ,Internal Revenue ,Liabilities From ,Accounting Standards Codification ,Based Payment ,Accounting Standards Update ,Jumpstart Our Business Startups Act ,Own Equity ,Accounting For Convertible Instruments ,Per Share ,Certain Modifications ,Freestanding Equity Classified Written Call ,Financial Accounting Standards Board ,Instruments Credit Losses Measurement ,Financial Instruments ,Securities Exchange Act ,Contract Assets ,Contract Liabilities ,Leumi Bank ,Inflammatory Bowel Disease ,Primary Sclerosing Cholangitis ,Through December ,Financial Conduct Authority ,License Agreement ,Development Company Limited ,Yeda Amendment ,Recapitalization Transaction ,Exit Fee ,Massachusetts Institute ,Patent License Agreement ,Agreement Effective ,Boehringer Ingelheim International Gmbh ,First Agreement Effective Date ,Final Report ,Second Agreement Effective Date ,Security Agreement ,Hercules Capital ,Loan Agreement ,Term Loan Facility ,Prime Rate ,Wall Street Journal ,Term Charge ,Public Offering ,Public Units ,Public Unit ,Public Warrants ,Sales Agreement ,Open Market Issuance Sales Agreement ,Additional Paid ,Purchase Agreement ,Milestone Payment ,Private Placement Warrants ,Direct Offering Warrants ,Incentive Plan ,Ordinary Share ,Israeli Income Tax Ordinance ,Revenue Code ,Corporate Restructuring ,Pre Funded Warrants ,Long Term Incentive Plan ,Israeli Government ,Security Cabinet ,Stock Option Plan ,Markets ,